ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135925 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135925; 2) Community: the network communities that were significantly associated with the response to NSC 135925; 3) Molecule: the relationships between components within communities and NSC 135925; 4) MDR: the compounds that were significantly associated with the NSC 135925.

NSC Compound Enrichment Correlation
NSC 348121 4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- 0.0410413740044188 0.51431922
NSC 355063 Granatomycin A 0.0410413740044188 0.21573792
NSC 376254 Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- 0.0410413740044188 0.3343068
NSC 403376 Null 0.0410413740044188 0.33919441
NSC 43675 General Chemicals 8993 0.0410413740044188 0.39127743
NSC 605756 Null 0.0410413740044188 0.22936716
NSC 635000 Null 0.0410413740044188 0.50959678
NSC 639504 Cyclopentanone, 2-[(dimethylamino)methyl]-5-octylidene-, hydrochloride 0.0410413740044188 0.43742478
NSC 641233 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- 0.0410413740044188 0.10427438
NSC 644966 Null 0.0410413740044188 -0.075945708
Total:44  Current:38    [First] [Prev] [Next] [Last]